Annals of Oncology 2010-02-01

The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control.

S J Proctor, A L Lennard, G H Jackson, G L Jones, J Lewis, J Wilkinson, J White, M Sieniawski, P McKay, D Culligan, H H Lucraft

Index: Ann. Oncol. 21(2) , 426-8, (2010)

Full Text: HTML

Related Compounds

Expression of O(6)-methylguanine-DNA methyltransferase causes lomustine resistance in canine lymphoma cells.

2015-07-01

[Can. J. Vet. Res. 79 , 201-9, (2015)]

Preliminary study of lomustine in the treatment of intracranial masses in dogs following localization by imaging techniques.

1990-11-01

[Semin. Vet. Med. Surg. Small Anim. 5(4) , 241-5, (1990)]

The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).

1982-12-01

[Cancer Treat. Rev. 9(4) , 313-30, (1982)]

Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil.

2002-08-01

[Clin. Endocrinol. (Oxf.) 57(2) , 169-83, (2002)]

High-dose etoposide in allogeneic stem cell transplantation.

2012-12-01

[Cancer Chemother. Pharmacol. 70(6) , 765-82, (2012)]